Clarify Health Appoints William Atkins CFO as the Company Heads Into its Next Growth Phase

09:00 EDT 13 May 2019 | Businesswire

Clarify Health Solutions, Inc.

Company continues expansion of executive team with the addition of seasoned finance and operations leadership

Clarify Health Solutions, Inc., a pioneer in advanced healthcare analytics and care optimization, announced today that William Atkins has joined the company as Chief Financial Officer (CFO). As CFO, Atkins will oversee Clarify's finance, and general and administrative functions.

“I am thrilled to welcome William to Clarify. William brings his experience building several public and private companies, where he was instrumental in providing the financial vision, strategy, and leadership to accelerate growth,” said Jean Drouin, CEO and co-founder, Clarify Health Solutions. “The energy and efficiency he brings to the role will undoubtedly have an immediate impact as we rapidly scale our customer base across the provider, payer, and life sciences sectors.”

Most recently, Atkins was Chief Financial Officer of Airobotics, where he was responsible for finance, human resources, and IT. Prior to Airobotics, he was Executive Vice President and Chief Financial Officer of NYSE-listed Calix, where he was responsible for finance and legal. He has also held CFO positions at Rivada Networks and at Intelsat. Earlier in his career, he was a senior investment banker at Morgan Stanley. With over 30 years of experience, Atkins has extensive exposure to the technology, media, and telecommunications sectors.

"I'm committed to helping Clarify build on its recent momentum, allocate resources against its greatest priorities, and continue its growth," said Atkins. "Clarify is a mission-driven team directing its immense talent towards delivering precision care analytics solutions. I see tremendous potential and look forward to putting my background and skills to work to help the Company achieve even greater results for our customers, employees, and investors."

Atkins has executed IPOs, mergers, acquisitions, debt restructurings, and private and public debt and equity financings in North America, Europe, and Asia. He has a Bachelor of Arts in History and a Master of Arts in East Asian Studies from Stanford University.

About Clarify Health Solutions

Clarify Health delivers the advanced analytics and digital solutions that empower physicians, health systems, payers and life science organizations to optimize clinical trials and patient care. The Clarify Health platform seamlessly integrates clinical, claims, social determinant, lab, and prescription data on over 150 million lives, and deploys machine learning and artificial intelligence to generate actionable insights. The power of Clarify’s cloud-based analytics stack, inspired by pioneering financial services analytics technology, drives the patient risk stratification, user engagement, and impact that differentiate our solutions. Clarify brings together committed colleagues with backgrounds in data science, big data engineering, and enterprise software, together with extensive clinical, operations, and change management expertise.

For more information, please visit and follow us on twitter @ClarifyHealth.

Media Contact
Kendall Reischl
Clarify Health Solutions


More From BioPortfolio on "Clarify Health Appoints William Atkins CFO as the Company Heads Into its Next Growth Phase"

Quick Search


Relevant Topics

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...